Epithalon

Epithalon and Cell Aging

Early research on insect and murine models hypothesized that Epithalon may improve cell span to a significant extent.[2]More specifically,epithalamin, a related pineal peptide preparation containing Epithalon, has been suggested to potentially increase the mean lifespan of insect and murine models by 11–31%. Furthermore, the experiment in rats suggested a 52% decrease in mortality upon Epithalon exposure. It appears to have been impactful in mice models of cardiac disease, where the life expectancy was reported to be increased by 27% compared to control animals. The peptide has been observed to mediate action by eliminating free radicals (charged molecules that damage tissue). More specifically, this potential antioxidative action of the peptide may inhibit free radical processes in both murine and insect models, and it is suggested that these antioxidative properties may potentially lead to increased lifespan in other test models. Apart from studies focused on its antioxidant activity, Epithalon has also been studied for its potential to activate an enzyme called telomerase in cell culture assays. Telomerase is considered to preserve the ends of chromosomes, known as telomeres, which are deemed crucial for maintaining the integrity of DNA. Epithalon may potentially preserve the DNA from damage by activating the telomerase and decreasing the number of errors in the DNA strands. This dual potential of enhancing antioxidant defense and possibly boosting telomere integrity might explain some of the lifespan-extending actions hypothesized in epithalamin and Epithalon models.

Another study posited that Epithalon might reduce intracellular reactive oxygen species (ROS) in aged oocyte cells, suggesting antioxidative characteristics.[3]Specifically, Epithalon appeared to decrease ROS accumulation significantly compared to higher concentrations, which did not yield the same protective action. This reduction in ROS might be crucial, as oxidative stress is considered a key factor in cellular aging. Epithalon also potentially preserves oocyte structural integrity. It was observed to decrease fragmentation rates in post-ovulatory aged oocytes and during parthenogenetic activation. Fragmentation, indicative of compromised cytoplasmic integrity, was notably reduced in the 0.1mM Epithalon group, implying a protective action on cellular morphology. Additionally, Epithalon appeared to maintain spindle integrity and proper cortical granule (CG) distribution. Spindle abnormalities, common in aged oocytes, appeared to have been mitigated by Epithalon, as was the mislocalization of CGs, which are essential for fertilization. These findings suggest that epithalons may help preserve the cytoskeletal and cortical structure of oocytes during aging. Mitochondrial function, a critical aspect of oocyte viability, appeared to be also positively affected by Epithalon. The study reported higher mitochondrial membrane potential and increased mtDNA copy numbers in Epithalon-exposed oocytes. Given that mitochondria are pivotal in ATP production and cellular energy metabolism, these findings propose that Epithalon may support mitochondrial integrity and functionality during oocyte aging. Furthermore, Epithalon experimentation seemed to reduce DNA damage and apoptosis in aged oocytes. The peptide decreased the fluorescence intensity of γH2AX signals, a marker of DNA damage, and appeared to have lowered apoptosis rates as indicated by Annexin-V staining. This implies that Epithalon might enhance oocyte survival by mitigating oxidative damage and preserving genomic stability.

Epithalon and DNA Activation and Gene Expression

Epithalon is being actively researched to explore the mechanisms by which this peptide may mediate longevity. One such potential pathway may be the regulation of certain gene expressions.[4]Studies evaluating the effect of peptide exposure in cell cultures have noted that Epithalon appears to directly interact with promoter regions of certain genes such as Tram1, IL-2, CD5, and MMP2 and may also enhance their expression. CD5 and IL-2 are both involved in the functions of the immune system, while MMP2 is considered to play a role in the maintenance of extracellular matrix in tendons, skin, and other connective tissue. Epithalon appears to trigger interferon-gamma synthesis from aging lymphocytes in rats. Interferon-gamma is a relevant signaling molecule of the immune system and supports combating viral infections through T lymphocyte, macrophage, and natural killer cell activation.

Another study investigated the potential mechanisms of the Epithalon in influencing gene expression and protein synthesis in stem cells such as gingival mesenchymal stem cells (hGMSCs).[5]The Epithalon peptide was suggested to induce neuronal cell differentiation in retinal and periodontal ligament stem cells (hPDLSCs). Epithalon peptide experimentation appeared to have led to an upregulation of neurogenic differentiation markers, including Nestin, GAP43, β Tubulin III, and Doublecortin, in hGMSCs. Specifically, mRNA expression of these markers increased by 1.6 to 1.8 times. This suggests a potential epigenetic mechanism where Epithalon peptide may regulate gene expression and protein synthesis related to neuronal differentiation. The study posits that the Epithalon peptide may interact specifically with histones, altering chromatin structure and thereby modulating gene expression. The Epithalon peptide's epigenetic regulation mechanism might involve competitive binding with histones at DNA interaction sites, increasing the likelihood of transcription for genes involved in neuronal differentiation. Molecular modeling indicated that Epithalon peptide may bind preferentially with histones H1/6 and H1/3 at specific sites, which may interact with DNA. This binding might facilitate increased transcription of neurogenic differentiation genes. The peptide-histone interaction might disrupt histone-DNA binding, potentially enhancing gene accessibility for transcription.

Epithalon and Extracellular Matrix (Skin ECM)

Experimental research suggests Epithalon’s potential to induce MMP2 expression. MMP2 is a protein found in connective tissue like skin. It may act as an enzyme with a potential role in the breakdown of extracellular matrix components, vital for tissue remodeling and repair. In the context of Epithalon, the induction of MMP2 expression might imply enhanced tissue regeneration and repair processes. Research in rodents indicates that apart from the activation of MMP2, the peptide might also activate fibroblasts, which produce and maintain MMP2 and other components of the extracellular matrix, such as collagen and elastin. Mice exposed to Epithalon exhibited 30-45% higher activation of fibroblasts than controls.[6]This increase in fibroblast activity suggests a possible route through which Epithalon may exert its actions on tissue repair and regeneration. Epithalon also appears to inhibit the activity of Caspase-3, a key enzyme that is considered to promote apoptosis (programmed cell death).[7]By inhibiting Caspase-3, Epithalon might contribute to cellular longevity and reduced apoptosis, which may complement its regenerative potential, yet this hypothesis demands more comprehensive research for validation.

Epithalon and Tumor Growth

Daily exposure to the peptide in rat models of cancerous tumors reported a reduction in tumor growth, with the burden diminishing the metastasis of the cells to distant tissues. Epithalon is currently under research for its interaction in Her-2/neu positive breast cancer, testicular cancer, and certain types of leukemia. Scientific research associates the peptide with activating the PER1 protein produced in the hypothalamus.[8]The gene is involved in regulating the circadian rhythm and is considered under-expressed in cancer instances. PER1 has been suggested to influence cancer progression once cancer has been established. It follows that control of PER1 expression may potentially be employed to reduce tumor growth. PER1 expression in cells appears to sensitize cancer cells to radiation. This is considered to exhibit a two-fold action. It may not only decrease tumor size and burden and decrease radiation, but it may also minimize the chances of secondary tumors from extensive radiation. Research is ongoing to further elucidate this hypothesis.

Epithalon and Melatonin Secretion

Melatonin is a hormone produced by the pineal gland that regulates sleep cycles. Studies on rats have suggested that Epithalon and similar peptides may potentially regulate the synthesis and secretion of melatonin by influencing the expression of two proteins: arylalkylamine-N-acetyltransferase (AANAT) and pCREB transcription protein.[9]These genes are believed to be involved in melatonin production and the circadian (day/night) control of hormone release. Research in monkeys observed that Epithalon may potentially restore normal physiological levels of melatonin.

Epithalon and Vision

Epithalon has been studied in rat models of retinitis pigmentosa.[10]These studies reported that the peptide appeared to improve the outcome in 90% of the cohort. Generally, research in Epithalon has suggested its potential to preserve the overall structure of the eye and boost the retina's bioelectric function, which is deemed important for fully functional vision.